...Ark first applied for approval in 2005 after mid-stage trial results, but was asked by regulators to perform a larger trial. AstraZeneca: The Anglo-Swedish drugs maker said that it hopes to sell a nasal spray flu vaccine in Europe; the product is already available...
• Pharma News
Powered By DaylifeOther company news pages:
- Abbott Labs
- Amgen
- AstraZeneca
- Bristol-Myers Squibb
- Eli Lilly
- Glaxo
- Roche
- J&J
- Merck
- Novartis
- Pfizer
- Sanofi-Aventis
- Schering-Plough
- Wyeth
AstraZeneca News
Dream Stocks for Biotech Investors
...the courts) including a recent challenge by AstraZeneca. The two settled, which allows Teva to sell a generic version of AstraZeneca's asthma treatment Pulmicort Respules until 2019, when the latter expects its patent to expire. The strong track record gives...
Kyp Systems Takes on the Challenge of New Pharmaceutical Marketing Guidelines
...proprietary technology creates a highly effective engagement experience, as demonstrated by the results we achieved for AstraZeneca through a turnkey direct mail application that connected physicians to a protected brand Web site." Kyp Systems, Inc. is the...
Exporters march higher across Japan, as the greenback garners strength against the yen
...for a recovery in DRAM contract prices. Across the pond in Europe, pharmaceutical firms were dominating headlines, with AstraZeneca (AZN) rallying 1.6% after the company said it applied for European approval for a flu vaccination product. In addition, automakers...
ABPI “battle plan” for informed patients does not exist, MPs told
...activity and stronger safeguards on the ârevolving doorâ between government and business. While Chris Brinsmead, president of AstraZeneca and the ABPI, was giving evidence to the inquiry, he was challenged by the panelâs chairman. Labour MP Dr Tony Wright,...
Company seeks approval for nasal spray flu vaccine
...the spread of influenza around the world," said Dr. Alex Zukiwski, chief medical officer of MedImmune, a subsidiary of AstraZeneca. The nasal spray is already marketed in the United States under the trade name FluMist. It was approved by the U.S. Food and...
Europe Markets: Shares in Europe extend 2009 winning streak
...AstraZeneca said that it has applied for European approval for a flu vaccination. Additionally, Porsche (DE:PAH003: news , chart , profile ) , down 0.9%, said that it will raise its stake in Volkswagen to 50.76%. Shares in British clothing chain operator...
Pharma buying spree could swallow biotechs
...has recently strengthened its portfolio by acquiring strategic products and subsidiaries in particular regions from rivals AstraZeneca and Bristol-Myers Squibb . Bankers, keen for important mandates at a time when deal flow has been drying up, predict a return...
Recipharm firms up French position
...unit will work in concert with Recipharmâs sterile manufacturing facility in Monts, also in France, that was purchased from AstraZeneca last July. The firm plans to use the additional capacity to diversify its product range and client base. In an interview...
Congress mandates disclosure
...education. And at the prodding of Sen. Chuck Grassley, who's among those leading the charge for disclosure regulation, AstraZeneca pledged to start posting payments for professional meetings and patient advocacy groups on its company website, and several other...
Clear
Clear